Optokinetic Nystagmus Weakens in Parkinson’s Disease and Tracks Freezing of Gait
A new eye-movement study places optokinetic nystagmus squarely in the clinical conversation around Parkinson’s disease. In a cohort of 251 patients with Parkinson’s disease and 46 age-matched healthy controls, investigators found that OKN gain was significantly reduced in the Parkinson group, then tied that abnormality to other oculomotor deficits and to a key bedside problem: freezing of gait.
The signal is clinically interesting because OKN reflects how the visual and motor systems cooperate to stabilize gaze during movement. When this reflex weakens, it may point to broader dysfunction in the networks that coordinate eye tracking, saccades, and smooth pursuit. In Parkinson’s disease, where basal ganglia circuitry is already disrupted, an impaired OKN response may function as a visible marker of that system-wide breakdown rather than an isolated eye sign.
A Broader Oculomotor Pattern, Not an Isolated Eye Finding
Participants underwent comprehensive oculomotor testing that included OKN, visually guided saccades, and smooth pursuit eye movements across three horizontal motion frequencies. The pattern that emerged was not random. OKN gain showed strong correlations with saccade latency and smooth pursuit gain at every tested frequency, while saccade accuracy did not track with OKN in the same way.
That separation matters physiologically. Saccade latency and pursuit gain depend on distributed control systems that overlap with ocular motor planning and motor initiation, both of which are vulnerable in Parkinson’s disease. A lower OKN gain alongside slower saccade initiation and weaker pursuit suggests a shared disturbance in sensorimotor timing, rather than a single failing reflex pathway. In practical terms, this points toward a measurable ocular phenotype that mirrors the disorder’s broader motor physiology.
One finding stood out sharply. After adjustment for confounding variables, OKN gain, not saccade latency, remained independently associated with freezing of gait.
Freezing of Gait Emerges as the Clinical Anchor
Among the eye-movement measures, OKN gain and saccade latency were associated primarily with the Freezing of Gait Questionnaire score and cognitive score. That pattern places the ocular findings near two of the most challenging dimensions of Parkinson’s disease: ambulatory motor arrest and cognitive decline. Freezing of gait is especially consequential because it drives falls, loss of mobility, and rapid functional deterioration, yet remains difficult to forecast in routine care.
The association between reduced OKN gain and freezing of gait suggests that visual-motor tracking deficits may reflect a phenotype with more complex network involvement. The reflex depends on coordinated sensory input and motor output, and its impairment may be a downstream expression of frontostriatal and visuomotor dysfunction. A patient whose eyes track poorly may be signaling more than ocular slowness; the abnormality may index a nervous system less able to integrate motion cues, a problem that can surface clinically as gait arrest in real-world movement.
Cognitive score also entered the same cluster of associations. This convergence supports a view of Parkinson’s disease in which eye movement abnormalities, gait instability, and cognition are intertwined rather than compartmentalized into separate subspecialty problems.
A Predictive Model Reached 80.4 Percent Accuracy
Investigators then built a model to predict the risk of freezing of gait. The model incorporated age, OKN gain, MDS-UPDRS-III scores, Chinese version of the Montreal Cognitive Assessment-Basic scores, and the presence of the wearing-off phenomenon. It reached an accuracy rate of 80.4%.
The composition of that model is clinically revealing. Age and MDS-UPDRS-III capture disease burden and motor severity. MoCA-BC contributes a cognitive dimension, while wearing-off reflects fluctuations in dopaminergic response. OKN gain added a visual-motor measure that appears to carry independent predictive information. In a disorder where bedside prediction is often limited by heterogeneity, an eye-movement variable that improves classification of freezing risk could help refine phenotyping, especially in patients whose gait symptoms are intermittent or difficult to capture during a single clinic visit.
The model does not convert OKN into a standalone diagnostic tool. What it does offer is a more integrated framework for risk estimation. The eye exam may become more useful when paired with standard motor and cognitive scales than when interpreted in isolation.
Why the Eye May Mirror the Motor System
Parkinson’s disease is not confined to limb bradykinesia or tremor. The same neurobiological disruption that affects initiation and scaling of movement can affect ocular motor circuits. OKN depends on smooth visual tracking and adaptive coordination between retinal slip signals and motor responses. If those loops deteriorate, the result is measurable reduction in gain. Because gait freezing also reflects impaired initiation and coordination, the shared association with impaired OKN is biologically plausible.
The study strengthens the idea that eye movement testing can serve as a window into distributed neural dysfunction in Parkinson’s disease. That does not mean the eyes replace neurological examination. It does mean ocular motor testing may identify a subgroup of patients with more severe sensorimotor vulnerability, especially when freezing of gait is part of the clinical picture.
What This Adds to Bedside Neurology
For clinicians, the most concrete implication is that reduced OKN gain may deserve attention during Parkinson’s evaluation, particularly when the history includes gait freezing, motor fluctuations, or cognitive complaints. The findings support a clinical approach that treats eye movement assessment as a meaningful biomarker candidate rather than a curiosity.
The dataset is substantial enough to support the association, but it remains observational, and the article does not establish whether impaired OKN predicts future freezing or simply co-travels with an already established phenotype. The cohort also came from a defined clinical setting, and the predictive model will need external validation before it can guide routine risk stratification. Even so, the study gives neurologists a new ocular measure tied directly to one of Parkinson’s disease’s most disabling complications.
A reduced OKN response may be doing more than reflecting eye movement impairment. It may be marking the network failure that helps a patient’s feet stop in place when the brain wants them to move.